<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Activated NF-kappaB contributes to <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> by triggering a neuro-<z:mp ids='MP_0001845'>inflammatory response</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Rats subjected to 90min middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> developed a cortical <z:mpath ids='MPATH_124'>infarct</z:mpath> of 20+/-4% of hemispheric volume (n = 8) </plain></SENT>
<SENT sid="2" pm="."><plain>Treatment with the <z:chebi fb="0" ids="52726">proteasome inhibitor</z:chebi> CVT-634 resulted in a significantly smaller <z:mpath ids='MPATH_124'>infarct</z:mpath> of 13+/-2% (n = 7, p&lt;0.01) and 12+/-2% (n = 8, p&lt;0.001) of hemispheric volume at 1 day and 7 days, respectively </plain></SENT>
<SENT sid="3" pm="."><plain>Since regional cerebral blood flows for the core and penumbral regions were not affected, we concluded that <z:hpo ids='HP_0000001'>all</z:hpo> animals received the same ischemic insult The reduction in infarction persisted for 7 days </plain></SENT>
<SENT sid="4" pm="."><plain>This is the first indication that a <z:chebi fb="0" ids="52726">proteasome inhibitor</z:chebi> can reduce <z:mpath ids='MPATH_124'>infarct</z:mpath> volume in a focal model of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
</text></document>